v3.26.1
Supplemental Income Statement Information - Scheduleof Disaggregated Revenues (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 27, 2026
Jun. 28, 2025
Jun. 27, 2026
Jun. 28, 2025
Disaggregation of Revenue [Line Items]        
Total revenues $ 11,994 $ 10,855 $ 22,999 $ 21,219
Life Sciences Solutions        
Disaggregation of Revenue [Line Items]        
Total revenues 2,355 2,115 4,574 4,069
Analytical Instruments        
Disaggregation of Revenue [Line Items]        
Total revenues 1,799 1,669 3,466 3,346
Specialty Diagnostics        
Disaggregation of Revenue [Line Items]        
Total revenues 1,188 1,118 2,312 2,248
Specialty Diagnostics | Intersubsegment Eliminations        
Disaggregation of Revenue [Line Items]        
Total revenues (75) (65) (145) (137)
Laboratory Products and Biopharma Services        
Disaggregation of Revenue [Line Items]        
Total revenues 6,652 5,953 12,647 11,556
Laboratory Products and Biopharma Services | Intersubsegment Eliminations        
Disaggregation of Revenue [Line Items]        
Total revenues (240) (238) (468) (453)
Total Reportable Segments        
Disaggregation of Revenue [Line Items]        
Total revenues 12,559 11,356 24,088 22,202
Total Reportable Segments | Life Sciences Solutions        
Disaggregation of Revenue [Line Items]        
Total revenues 2,815 2,499 5,450 4,840
Total Reportable Segments | Life Sciences Solutions | Biosciences        
Disaggregation of Revenue [Line Items]        
Total revenues 1,060 1,075 2,040 2,068
Total Reportable Segments | Life Sciences Solutions | Genetic sciences        
Disaggregation of Revenue [Line Items]        
Total revenues 703 679 1,358 1,356
Total Reportable Segments | Life Sciences Solutions | BioProduction        
Disaggregation of Revenue [Line Items]        
Total revenues 941 745 1,834 1,416
Total Reportable Segments | Life Sciences Solutions | Other        
Disaggregation of Revenue [Line Items]        
Total revenues 112 0 219 0
Total Reportable Segments | Analytical Instruments        
Disaggregation of Revenue [Line Items]        
Total revenues 1,847 1,728 3,563 3,446
Total Reportable Segments | Analytical Instruments | Chromatography and mass spectrometry        
Disaggregation of Revenue [Line Items]        
Total revenues 821 784 1,620 1,557
Total Reportable Segments | Analytical Instruments | Chemical analysis        
Disaggregation of Revenue [Line Items]        
Total revenues 318 292 603 578
Total Reportable Segments | Analytical Instruments | Electron microscopy        
Disaggregation of Revenue [Line Items]        
Total revenues 707 652 1,340 1,311
Total Reportable Segments | Specialty Diagnostics        
Disaggregation of Revenue [Line Items]        
Total revenues 1,205 1,134 2,346 2,282
Total Reportable Segments | Specialty Diagnostics | Clinical diagnostics        
Disaggregation of Revenue [Line Items]        
Total revenues 290 276 561 539
Total Reportable Segments | Specialty Diagnostics | ImmunoDiagnostics        
Disaggregation of Revenue [Line Items]        
Total revenues 248 234 478 451
Total Reportable Segments | Specialty Diagnostics | Microbiology        
Disaggregation of Revenue [Line Items]        
Total revenues 166 159 326 311
Total Reportable Segments | Specialty Diagnostics | Transplant diagnostics        
Disaggregation of Revenue [Line Items]        
Total revenues 134 124 255 237
Total Reportable Segments | Specialty Diagnostics | Healthcare market channel        
Disaggregation of Revenue [Line Items]        
Total revenues 442 407 873 880
Total Reportable Segments | Laboratory Products and Biopharma Services        
Disaggregation of Revenue [Line Items]        
Total revenues 6,693 5,995 12,729 11,635
Total Reportable Segments | Laboratory Products and Biopharma Services | Laboratory products        
Disaggregation of Revenue [Line Items]        
Total revenues 608 601 1,176 1,183
Total Reportable Segments | Laboratory Products and Biopharma Services | Research and safety market channel        
Disaggregation of Revenue [Line Items]        
Total revenues 2,036 1,883 3,863 3,610
Total Reportable Segments | Laboratory Products and Biopharma Services | Pharma services        
Disaggregation of Revenue [Line Items]        
Total revenues 1,893 1,794 3,634 3,401
Total Reportable Segments | Laboratory Products and Biopharma Services | Clinical research        
Disaggregation of Revenue [Line Items]        
Total revenues 2,396 1,955 4,524 3,894
Elimination of intersegment revenues        
Disaggregation of Revenue [Line Items]        
Total revenues (565) (501) (1,089) (983)
North America        
Disaggregation of Revenue [Line Items]        
Total revenues 6,149 5,722 11,854 11,235
Europe        
Disaggregation of Revenue [Line Items]        
Total revenues 3,311 2,830 6,268 5,454
Asia-Pacific        
Disaggregation of Revenue [Line Items]        
Total revenues 2,104 1,920 4,075 3,811
Other regions        
Disaggregation of Revenue [Line Items]        
Total revenues 430 383 802 720
Product revenues        
Disaggregation of Revenue [Line Items]        
Total revenues 6,823 6,249 13,100 12,229
Consumables        
Disaggregation of Revenue [Line Items]        
Total revenues 5,073 4,606 9,794 8,960
Instruments        
Disaggregation of Revenue [Line Items]        
Total revenues 1,750 1,644 3,305 3,270
Services        
Disaggregation of Revenue [Line Items]        
Total revenues $ 5,171 $ 4,605 $ 9,899 $ 8,990